Authors:
GAEDIGK A
TYNDALE RF
JURIMAROMET M
SELLERS EM
GRANT DM
LEEDER JM
Citation: A. Gaedigk et al., NAD(P)H-QUINONE OXIDOREDUCTASE - POLYMORPHISMS AND ALLELE FREQUENCIESIN CAUCASIAN, CHINESE AND CANADIAN NATIVE INDIAN AND INUIT POPULATIONS, Pharmacogenetics, 8(4), 1998, pp. 305-313
Authors:
DROLL K
BRUCEMENSAH K
OTTON SV
GAEDIGK A
SELLERS EM
TYNDALE RF
Citation: K. Droll et al., COMPARISON OF 3 CYP2D6 PROBE SUBSTRATES AND GENOTYPE IN GHANAIANS, CHINESE AND CAUCASIANS, Pharmacogenetics, 8(4), 1998, pp. 325-333
Authors:
ZAWERTAILO LA
KAPLAN HL
BUSTO UE
TYNDALE RF
SELLERS EM
Citation: La. Zawertailo et al., PSYCHOTROPIC EFFECTS OF DEXTROMETHORPHAN ARE ALTERED BY THE CYP2D6 POLYMORPHISM - A PILOT-STUDY, Journal of clinical psychopharmacology, 18(4), 1998, pp. 332-337
Authors:
BRONSTEIN JM
HALES TG
TYNDALE RF
CHARLES AC
Citation: Jm. Bronstein et al., A CONDITIONALLY IMMORTALIZED GLIAL-CELL LINE THAT EXPRESSES MATURE MYELIN PROTEINS AND FUNCTIONAL GABA(A) RECEPTORS, Journal of neurochemistry, 70(2), 1998, pp. 483-491
Authors:
TYNDALE RF
MIKSYS S
HOFFMANN E
TAMPAKERAS M
TOMKINS DM
Citation: Rf. Tyndale et al., DIFFERENT ALCOHOL-DRINKING PROPENSITIES ARE REFLECTED IN SUBUNIT-SPECIFIC AND REGION-SPECIFIC GABA(A) RECEPTORS LEVELS, Journal of neurochemistry, 70, 1998, pp. 28-28
Citation: Mp. Nowak et al., CANADIAN NATIVE INDIANS EXHIBIT UNIQUE CYP2A6 AND CYP2C19 MUTANT ALLELE FREQUENCIES, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 378-383
Authors:
ZEMAN MV
PIANEZZA ML
LI NY
TYNDALE RF
SELLERS EM
Citation: Mv. Zeman et al., CHARACTERIZATION OF CYP2A6 ACTIVITY USING PLASMA COUMARIN MEASUREMENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 32-32
Authors:
ZAWERTAILO LA
BUSTO UE
TYNDALE RF
SELLERS EM
Citation: La. Zawertailo et al., DEXTROMETHORPHANS ACTIVE METABOLITE CONTRIBUTES TO ITS ABUSE LIABILITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 39-39
Authors:
GAEDIGK A
TYNDALE RF
JURIMAROMET M
SELLERS EM
LEEDER JS
Citation: A. Gaedigk et al., GENETIC POLYMORPHISMS IN THE NAD(P)H - QUINONE OXIDOREDUCTASE (NQO1) GENE LOCUS, Clinical pharmacology and therapeutics, 63(2), 1998, p.
Authors:
CHEUNG S
NOLTE H
OTTON SV
TYNDALE RF
WU PH
SELLERS EM
Citation: S. Cheung et al., SIMULTANEOUS GAS-CHROMATOGRAPHIC DETERMINATION OF METHAMPHETAMINE, AMPHETAMINE AND THEIR P-HYDROXYLATED METABOLITES IN PLASMA AND URINE, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 77-87
Authors:
TYNDALE RF
BHAVE SV
HOFFMANN E
HOFFMAN PL
TABAKOFF B
TOBIN AJ
OLSEN RW
Citation: Rf. Tyndale et al., PENTOBARBITAL DECREASES THE GAMMA-AMINOBUTYRIC ACID(A) RECEPTOR SUBUNIT GAMMA-2 LONG SHORT MESSENGER-RNA RATIO BY A MECHANISM DISTINCT FROMRECEPTOR OCCUPATION/, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 350-357
Citation: Es. Messina et al., A MAJOR ROLE FOR CYP2A6 IN NICOTINE C-OXIDATION BY HUMAN LIVER-MICROSOMES, The Journal of pharmacology and experimental therapeutics, 282(3), 1997, pp. 1608-1614
Authors:
TOMKINS DM
OTTON SV
JOHARCHI N
LI NY
BALSTER RF
TYNDALE RF
SELLERS EM
Citation: Dm. Tomkins et al., EFFECT OF CYTOCHROME-P450 2D1 INHIBITION ON HYDROCODONE METABOLISM AND ITS BEHAVIORAL CONSEQUENCES IN RATS, The Journal of pharmacology and experimental therapeutics, 280(3), 1997, pp. 1374-1382
Authors:
ROMACH MK
KATHIRAMALAINATHAN K
KAPLAN HL
BUSTO UE
TYNDALE RF
SELLERS EM
Citation: Mk. Romach et al., CODEINE ABUSE LIABILITY IS MODIFIED BY CYP2D6 INHIBITION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 107-107
Citation: Em. Sellers et al., TOBACCO AND OTHER DRUG-DEPENDENCE INCREASES VARIATION IN CYTOCHROME-P450 3A ACTIVITY (CYP3A) IN FEMALES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 108-108
Authors:
TYNDALE RF
BHAVE SV
HOFFMAN PL
TABAKOFF B
TOBIN AJ
OLSEN RW
Citation: Rf. Tyndale et al., THE GABA(A) RECEPTOR SUBUNIT-GAMMA-2 L S RATIO IS ALTERED AFTER PENTOBARBITAL TREATMENT/, Journal of neurochemistry, 66, 1996, pp. 58-58
Authors:
OCAMPO JA
BUSTO UE
KAPLAN HL
TYNDALE RF
OTTON SV
NOLTE H
SYMANZIK C
SELLERS EM
Citation: Ja. Ocampo et al., DOES EXTENT OF P-HYDROXYLATION ALTER METHAMPHETAMINE KINETICS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 83-83